Prognostic markers in AIDS-related cryptococcal meningitis.

OBJECTIVE Despite the advent and expanding access to antiretroviral therapy, HIV-associated cryptococcal meningitis (CM) remains a significant cause of mortality and morbidity amongst individuals with this infection in resource-limited settings. METHODS We prospectively studied the clinical, biochemical and mycological parameters of 30 HIV patients diagnosed with cryptococcal meningitis at our centre over a period of 6 months with a view to identify prognostic factors predictive of poor outcome. RESULTS Our study documented a mortality rate of 36.7%. Age, sex and previous diagnosis of HIV had no bearing on the survival outcome of patients. The study identified several poor prognostic factors including low GCS score, papilledema, elevated CSF opening pressure (>250 mm of H2O) and lack of regular HIV care in those with a prior diagnosis of HIV. CSF pleocytosis was significantly higher in the mortality group. CONCLUSION There have been relatively few attempts to focus on poor prognostic markers associated with AIDS related Cryptococcal meningitis in Asian patients. Our study highlights how simple bedside clinical tools like ophthalmoscopy and CSF manometry can help in risk stratification in this group of patients.

[1]  T. Harrison,et al.  Lumbar drainage for control of raised cerebrospinal fluid pressure in cryptococcal meningitis: case report and review. , 2005, The Journal of infection.

[2]  J. Andonaba,et al.  [Cryptococcal meningitis in HIV-infected patients at Bobo-Dioulasso hospital (Burkina Faso)]. , 2004, Bulletin de la Societe de pathologie exotique.

[3]  A. Simpson,et al.  A prospective study of AIDS-associated cryptococcal meningitis in Thailand treated with high-dose amphotericin B. , 2001, The Journal of infection.

[4]  S. Shankar,et al.  Cryptococcosis in the immunocompromised host with special reference to AIDS. , 2000, The Indian journal of chest diseases & allied sciences.

[5]  R. Chaisson,et al.  Risk factors for cryptococcal meningitis in HIV-infected patients. , 1999, AIDS research and human retroviruses.

[6]  L. Pirofski,et al.  Cryptococcosis in children with AIDS. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[7]  Y. Coovadia,et al.  Cryptococcal meningitis in Durban, South Africa: a comparison of clinical features, laboratory findings, and outcome for human immunodeficiency virus (HIV)-positive and HIV-negative patients. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[8]  S. Chevret,et al.  Cryptococcus neoformans infection in France: epidemiologic features of and early prognostic parameters for 76 patients who were infected with human immunodeficiency virus. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[9]  D. Ellis,et al.  Ecology, life cycle, and infectious propagule of Cryptococcus neoformans , 1990, The Lancet.